|
|
|
Insider
Information: |
Maraganore John |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
263,534 |
|
Indirect Shares
|
6,153,633 |
|
|
Direct
Value |
$36,217,274 |
|
|
Indirect Value
|
$14,194,275 |
|
|
Total
Shares |
6,417,167 |
|
|
Total
Value |
$50,411,549 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2021-12-22 |
227,663 |
2021-12-22 |
3,133 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
30,028 |
|
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Director |
2017-09-14 |
5,843 |
2014-07-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-29 |
4 |
AS |
$15.60 |
$269,298 |
D/D |
(17,089) |
1,689 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-28 |
4 |
AS |
$16.05 |
$280,262 |
D/D |
(17,431) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2012-12-19 |
4 |
OE |
$0.48 |
$8,843 |
D/D |
18,617 |
77,120 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-29 |
4 |
AS |
$15.23 |
$287,605 |
D/D |
(18,722) |
18,778 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-09-14 |
4 |
OE |
$2.09 |
$39,434 |
D/D |
18,868 |
24,711 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-09-14 |
4 |
S |
$131.19 |
$2,475,733 |
D/D |
(18,868) |
5,843 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-28 |
4 |
AS |
$15.78 |
$320,253 |
D/D |
(20,069) |
17,431 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-12-12 |
4 |
D |
$42.61 |
$967,673 |
D/D |
(22,710) |
148,370 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
|
2006-05-12 |
4 |
AS |
$15.01 |
$428,070 |
D/D |
(28,313) |
18,457 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-02-28 |
4 |
AS |
$23.50 |
$669,900 |
D/D |
(28,503) |
18,617 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2014-04-14 |
4 |
OE |
$9.14 |
$524,962 |
D/D |
28,707 |
106,320 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-02-27 |
4 |
AS |
$23.47 |
$704,019 |
D/D |
(30,000) |
47,120 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-12-12 |
4 |
OE |
$22.75 |
$685,935 |
D/D |
30,151 |
171,080 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-11-12 |
4 |
OE |
$7.10 |
$241,244 |
D/D |
33,978 |
248,743 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-11-12 |
4 |
AS |
$170.36 |
$5,827,801 |
D/D |
(33,978) |
214,765 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-02-25 |
4 |
OE |
$7.10 |
$241,251 |
D/D |
33,979 |
240,015 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-02-25 |
4 |
AS |
$143.88 |
$5,005,421 |
D/D |
(33,979) |
206,036 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-05-13 |
4 |
OE |
$7.10 |
$241,251 |
D/D |
33,979 |
248,744 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-05-13 |
4 |
AS |
$128.30 |
$4,443,725 |
D/D |
(33,979) |
214,765 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-08-13 |
4 |
OE |
$7.10 |
$241,251 |
D/D |
33,979 |
248,744 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2021-08-13 |
4 |
AS |
$198.02 |
$6,788,196 |
D/D |
(33,979) |
214,765 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-02-20 |
4 |
AS |
$128.62 |
$4,583,674 |
D/D |
(34,765) |
189,993 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-02-20 |
4 |
OE |
$9.14 |
$317,752 |
D/D |
34,765 |
224,758 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-05-20 |
4 |
AS |
$142.51 |
$4,978,983 |
D/D |
(34,765) |
197,589 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-05-20 |
4 |
OE |
$9.14 |
$317,752 |
D/D |
34,765 |
232,354 |
0 |
- |
|
154 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|